FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA

Document

No Title 0.49 MB
Registration Date 27 Jul 2016
Share

JUVISYNC™

(0)

Medicine Pharmaceuticals Product Number : 0006-0757-14

Antihyperlipidemic

Drug Information

Generic
Simvastatin and sitagliptin
NDC Code
0006-0757-14
Drug Class
Sitagliptin
Therapeutic Class
Antidiabetic combinations
Dosage form
tablet
Route of Administration
Oral
Therapeutic Area
1.Antihyperlipidemic

Indication

type II diabetes Juvisync™ (sitagliptin and simvastatin) is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Juvisync is used in people with type 2 diabetes who also have high cholesterol or triglycerides (types of fat) in the blood. This medication is not for treating type 1 diabetes. Juvisync is also used to lower the risk of stroke, heart attack, and other heart complications in people with diabetes, coronary heart disease, or other risk factors

Benefit

This is the first product to combine a type 2 diabetes drug with a cholesterol lowering drug in one table